Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20230909059383N1Phase 3Completed
Phase 3 trial of succinylcholine and rocuronium in None (2 arms), sponsored by Islamic Azad University. Primary endpoints: Hemodynamic changes (heart rate) and Hemodynamic changes (blood pressure). Started Apr 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20230909059383N1.